RE:RE:Another great move by aphriaMy initial gut reaction is I like it, but jury still out. I like that they earn 8% on their fully secured investment assuming their is 11.5 million value in the assets.
They have two years to decide if they want to convert to common shares at $2.70 price.
I believe Hydrx Farm raised cash earlier in the year by way of private placement at $2.60 per share.
Need to look further into how Hydrx intends to monetize their formulations of cannabinoid compounds, which should happen later this year and into 2018. Hence the need for supply of plants.
GoBlue2016 wrote: Interesting.
Since SF isn't publically traded they took a security charge (General Security Agreement) over all their assets.
But they still have the convertible feature. So SF will likely go public within next two years.
Would love a rundown on what their patent pending is about.
GoBlue
Berta11 wrote: BRIEF-Aphria announces $11.5 mln strategic investment in Scientus Pharma 19 minutes ago - Reuters
BRIEF-Aphria announces $11.5 mln strategic investment in Scientus Pharma Aug 15 (Reuters) - Aphria Inc
* Aphria announces $11.5 million strategic investment in Scientus Pharma
* Aphria Inc - Invested $11.5 million in Hydrx Farms, Ltd by way of a senior, secured convertible debenture
* Aphria Inc - Debenture has a two-year term and is convertible into common shares of Scientus Pharma at rate of $2.75 a share Source text for Eikon: Further company coverage: